Abstract
Objectives Through searching and summarizing the medication-related
disputes and claims in Beijing, we found the factors that were most
likely to cause disputes during the medication process. These provided a
basis for further exploration of medication-related dispute prevention
and control measures. Methods We took all medication-related dispute
archives from the Beijing People’s Mediation Committee of Medical
Disputes(BPMCMD)database from January 2013 to December 2019 as the
research object, and used pre-designed forms for data extraction and
entry. Results Medication-related disputes accounted for 2.43% of the
total number of disputes, of which 158 disputes got the payment from
hospitals. There were obviously more disputes between women than men.
The most disputes occurred in outpatient clinics, followed by
hospitalization and emergency treatment. Disputes were most likely to
occur in pharmacy, respiratory medicine, pediatrics, neurology and
orthopedics. Antibacterial drugs were the most common drugs that caused
disputes, followed by herbal medicines or Chinese patent drugs,
antineoplastic drugs, analgesic drugs, psycholeptics drugs and
antithrombotic agents. Medication errors mainly concentrated in
inappropriate drugs (within guidelines, but otherwise contraindicated);
wrong drugs or strength dispensed; drug dose too high and no indications
for drug. The main cause of disputes was adverse drug events. The total
compensation for seven years was 15.19 million yuan. Conclusions We
comprehensively displayed the dispute data from the patient, the doctor,
the drug, and the compensation, etc. The research would help Beijing and
other regions formulate the strategies to reduce medication errors,
improve patient safety, and reduce medication-related dispute